Clinical significance of prostate-specific antigen density in patients with serum prostate specific antigen between 4 and 10ng/ml

Korean Journal of Urology

Volumn 47, Issue 11, 2006, Pages 1161-1165

  Kim, Byoung Kun ^a   Chang, Hyuk Soo ^a   Kim, Chun Il ^a  

^a Keimyung University School of Medicine   (South Korea)

Author keywords

Prostate cancer; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; IMMUNOLOGICAL PARAMETERS; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 33846899047     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2006.47.11.1161     Document Type: Article

References (17)

1. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate specific antigen. Invest Urol 1979;17: 159-63
2. Stamey TA, Caldwell M, McNeal JE, Nolley R, Hemenez M, Downs J. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol 2004;172:1297-301
3. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994;151:1283-90
4. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-23
5. Egawa S, Matsumoto K, Yoshida K, Iwamura M, Kuwao S, Koshiba K. Results of transrectal ultrasound-guided biopsies and clinical significance of Japanese prostate cancer. Jpn J Clin Oncol 1998;28:666-72
6. Kobayashi T, Nishizawa K, Ogura K, Mitsumori K, Ide Y. Detection of prostate cancer in men with prostate-specific antigen levels of 2.0 to 4.0ng/ml equivalent to that in men with 4.1 to 10.0ng/ml in a Japanese population. Urology 2004;63: 727-31
7. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 1992;147:817-21
8. Bazinet M, Meshref AW, Trudel C, Aronson S, Peloquin F, Nachabe M, et al. Prospective evaluation of prostate specific antigen density and systematic biopsies for early detection of prostate carcinoma. Urology 1994;43:44-51
9. Ramon J, Boccon-Gibod L, Billebaud T, Astior L, Kobelinsky M, Meulemans A, et al. Prostate-specific antigen density: a means to enhance detection of prostate cancer. Eur Urol 1994; 25:288-94
10. Brawer MK, Aramburu EA, Chen GL, Preston SD, Ellis WJ. The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma. J Urol 1993;150:369-73
11. Akdas A, Tarcan T, Turkeri L, Cevik I, Biren T, Gurmen N. The diagnostic accuracy of digital rectal examination, transrectal ultrasonography, prostate-specific antigen (PSA) and PSA density in prostate carcinoma. Br J Urol 1995;76:54-6
12. Lee SE, Jung JY, Cho KS, Byeon SS, Kim KM, Paick JS. The value of prostate specific antigen density in the diagnosis of prostate carcinoma. Korean J Urol 1988;39:355-60
13. Lee SE, Jung BC, Kim TH, Jeong SJ, Kwak C. The clinical usefulness of the prostate-specific antigen density, digital rectal examination, and transrectal ultrasonography in the screening test of prostate cancer in Koreans. Korean J Urol 2002;43:14-8
14. Kim WJ, Lee SC, Lee SC. Value of PSA density, PSA velocity and percent free PSA for detection of prostate cancer in patients with serum PSA 4-10ng/ml patients. Korean J Urol 2004;45:747-52
15. Andriole GL, Telle WB, Coplen DE, Catalona WJ. PSA index (PSAI) as a predictor of prostate cancer (CAP) in men with persistent serum PSA elevation. J Urol 1992;147(Suppl):387
16. Benson MC, McMahorn DJ, Cooner WH, Olsson CA. An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate specific antigen density. World J Urol 1993;11:206-13
17. Yu HJ, Lai MK. The usefulness of prostate-specific antigen (PSA) density in patients with intermediate serum PSA level in a country with low incidence of prostate cancer. Urology 1998;51(5A Suppl):125-30